Valosin-containing protein regulates the stability of fused in sarcoma granules in cells by changing ATP concentrations

FEBS Lett. 2022 Jun;596(11):1412-1423. doi: 10.1002/1873-3468.14353. Epub 2022 Apr 25.

Abstract

Fused in sarcoma (FUS), a DNA/RNA-binding protein, undergoes liquid-liquid phase separation to form granules in cells. Aberrant FUS granulation is associated with neurodegenerative diseases, including amyotrophic lateral sclerosis and frontotemporal lobar degeneration. We found that FUS granules contain a multifunctional AAA ATPase, valosin-containing protein (VCP), which is known as a key regulator of protein degradation. FUS granule stability depends on ATP concentrations in cells. VCP ATPase changes the FUS granule stability time-dependently by consuming ATP to reduce its concentrations in the granules: VCPs in de novo FUS granules stabilize the granules, while long-lasting VCP colocalization destabilizes the granules. The proteolysis-promoting function of VCP may subsequently dissolve the unstabilized granules. We propose that VCP colocalized to the FUS granules acts as a timer to limit the residence time of the granules in cells.

Keywords: ALS; ATP; FUS; VCP; liquid-liquid phase separation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate
  • Amyotrophic Lateral Sclerosis* / metabolism
  • Frontotemporal Lobar Degeneration* / metabolism
  • Humans
  • RNA-Binding Protein FUS / genetics
  • RNA-Binding Protein FUS / metabolism
  • Sarcoma*
  • Valosin Containing Protein / genetics
  • Valosin Containing Protein / metabolism

Substances

  • RNA-Binding Protein FUS
  • Adenosine Triphosphate
  • Valosin Containing Protein